77 related articles for article (PubMed ID: 18195528)
21. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
Park SH; Lee WK; Chung M; Bang SM; Cho EK; Lee JH; Shin DB
Cancer Chemother Pharmacol; 2006 Feb; 57(3):289-94. PubMed ID: 16010588
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1.
Shitara K; Muro K; Ura T; Takahari D; Yokota T; Sawaki A; Kawai H; Ito S; Yamamura Y
Jpn J Clin Oncol; 2008 Nov; 38(11):786-9. PubMed ID: 18820010
[TBL] [Abstract][Full Text] [Related]
25. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/ leucovorin (FOLFOX-4 chemotherapy)].
Garrido M; Melgoza G; Galindo H; Madrid J; Sánchez C; Nervi B; Alvarez M; Orellana E
Rev Med Chil; 2007 Nov; 135(11):1380-7. PubMed ID: 18259648
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy after second-line chemotherapy for patients with advanced or metastatic breast cancer].
Ogasawara Y; Doihara H; Takahashi M; Kawasaki K; Taira N
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1713-6. PubMed ID: 18931574
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer.
Nagata N; Kimura M; Hirabayashi N; Tuburaya A; Murata T; Kondo K; Fukuda Y; Kobayashi M; Miyashita Y; Nakao A; Sakamoto J
Hepatogastroenterology; 2008; 55(86-87):1846-50. PubMed ID: 19102406
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
31. [A case report-the marked response to S-1 + CDDP chemotherapy for post-operative local recurrence of advanced gastric cancer].
Watanabe F; Iwasaki Y; Ohashi M; Nunobe S; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1970-2. PubMed ID: 18219868
[TBL] [Abstract][Full Text] [Related]
32. New chemotherapy strategies for gastric cancer.
Kubota T
In Vivo; 2008; 22(3):273-8. PubMed ID: 18610735
[TBL] [Abstract][Full Text] [Related]
33. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
34. Advanced gastric cancer--slow but steady progress.
Power DG; Kelsen DP; Shah MA
Cancer Treat Rev; 2010 Aug; 36(5):384-92. PubMed ID: 20176443
[TBL] [Abstract][Full Text] [Related]
35. The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer.
Yamazaki K; Boku N; Shibamoto K; Yasui H; Fukutomi A; Yoshino T; Hironaka S; Onozawa Y; Otake Y; Hasuike N; Matsubayashi H; Inui T; Yamaguchi Y; Ono H
Jpn J Clin Oncol; 2007 Feb; 37(2):96-101. PubMed ID: 17272316
[TBL] [Abstract][Full Text] [Related]
36. [Third-line CPT-11 chemotherapy for gastric cancer cases of non-curative gastrectomy or recurrence].
Kawamura H; Yokota R; Watarai H; Yokota K; Tanioka T; Tsunoda Y; Masuko H; Tanaka K; Yamagami H; Hata T; Okada K; Ishizu H; Kondo Y
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1051-4. PubMed ID: 20567106
[TBL] [Abstract][Full Text] [Related]
37. Recent developments in chemotherapy of advanced gastric cancer.
Götze T; Schütte K; Röcken C; Malfertheiner P; Ebert MP
Dig Dis; 2004; 22(4):360-5. PubMed ID: 15812160
[TBL] [Abstract][Full Text] [Related]
38. [Oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer patients].
Nishimura T; Sakata K; Nakamura M; Okada T; Fukuda Y; Tanaka S; Seiki M; Takemura Y; Yamashita S
Gan To Kagaku Ryoho; 2010 Dec; 37 Suppl 2():243-5. PubMed ID: 21368538
[TBL] [Abstract][Full Text] [Related]
39. Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
Chrom P; Stec R; Szczylik C
Anticancer Res; 2015 Sep; 35(9):4575-83. PubMed ID: 26254345
[TBL] [Abstract][Full Text] [Related]
40. [Cancer and appendicitis--death due to incidental appendicitis in recurrent stomach cancer with successful chemotherapy].
Saito T; Nozaki H; Kanamaru R; Isono S; Kurobane T
Gan No Rinsho; 1968 Jun; 14(6):515-22. PubMed ID: 5748510
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
